Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Langerhans Cells | 2 | 2018 | 194 | 1.340 |
Why?
|
Histiocytosis, Sinus | 2 | 2017 | 49 | 0.790 |
Why?
|
Pancytopenia | 1 | 2019 | 107 | 0.760 |
Why?
|
Histiocytic Sarcoma | 1 | 2019 | 43 | 0.750 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2021 | 1307 | 0.750 |
Why?
|
Esophageal Fistula | 1 | 2018 | 56 | 0.740 |
Why?
|
Leukemic Infiltration | 1 | 2018 | 50 | 0.740 |
Why?
|
Histiocytes | 1 | 2018 | 101 | 0.710 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2018 | 78 | 0.710 |
Why?
|
Blood Cells | 1 | 2019 | 324 | 0.680 |
Why?
|
Carcinoma | 2 | 2018 | 2353 | 0.610 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2021 | 3027 | 0.610 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2017 | 171 | 0.600 |
Why?
|
Cyclin D1 | 1 | 2017 | 499 | 0.590 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 1252 | 0.570 |
Why?
|
Urine | 1 | 2016 | 396 | 0.570 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2021 | 1394 | 0.530 |
Why?
|
Urothelium | 1 | 2016 | 334 | 0.520 |
Why?
|
ras Proteins | 1 | 2019 | 1141 | 0.490 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1583 | 0.470 |
Why?
|
MAP Kinase Signaling System | 1 | 2019 | 1617 | 0.430 |
Why?
|
Cell Differentiation | 2 | 2018 | 11833 | 0.410 |
Why?
|
Bone Marrow Cells | 1 | 2018 | 2698 | 0.400 |
Why?
|
Esophageal Neoplasms | 1 | 2018 | 1525 | 0.380 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3557 | 0.320 |
Why?
|
Skin | 1 | 2018 | 4456 | 0.270 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2119 | 0.270 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 25 | 0.220 |
Why?
|
Mycosis Fungoides | 1 | 2021 | 150 | 0.200 |
Why?
|
Dura Mater | 1 | 2021 | 288 | 0.190 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 170 | 0.190 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2021 | 193 | 0.190 |
Why?
|
Scalp | 1 | 2021 | 348 | 0.180 |
Why?
|
B-Lymphocytes | 3 | 2021 | 4913 | 0.180 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 744 | 0.170 |
Why?
|
Biopsy | 3 | 2019 | 6849 | 0.160 |
Why?
|
Cervix Uteri | 1 | 2021 | 564 | 0.160 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2016 | 91 | 0.160 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 548 | 0.150 |
Why?
|
Immunophenotyping | 2 | 2019 | 1915 | 0.150 |
Why?
|
Staining and Labeling | 1 | 2020 | 1140 | 0.150 |
Why?
|
Mutation | 5 | 2021 | 28848 | 0.140 |
Why?
|
Autopsy | 1 | 2018 | 975 | 0.140 |
Why?
|
Workflow | 1 | 2019 | 734 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1915 | 0.140 |
Why?
|
Immunohistochemistry | 3 | 2019 | 12095 | 0.130 |
Why?
|
Aortic Diseases | 1 | 2018 | 744 | 0.120 |
Why?
|
Genetic Association Studies | 2 | 2019 | 2722 | 0.120 |
Why?
|
Middle Aged | 10 | 2021 | 216468 | 0.120 |
Why?
|
Cardiovascular System | 1 | 2018 | 744 | 0.120 |
Why?
|
Aged, 80 and over | 4 | 2019 | 59331 | 0.120 |
Why?
|
Gastrointestinal Tract | 1 | 2018 | 845 | 0.120 |
Why?
|
Humans | 19 | 2021 | 686663 | 0.110 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1210 | 0.110 |
Why?
|
Tobacco Use Disorder | 1 | 2016 | 698 | 0.100 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2628 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1371 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2016 | 1799 | 0.100 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 2503 | 0.100 |
Why?
|
Aged | 6 | 2020 | 162271 | 0.100 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 1911 | 0.090 |
Why?
|
Male | 10 | 2020 | 352465 | 0.090 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 3053 | 0.090 |
Why?
|
Disease Management | 1 | 2019 | 2586 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2018 | 6230 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2021 | 2606 | 0.080 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 2656 | 0.080 |
Why?
|
Genetic Testing | 1 | 2019 | 3230 | 0.080 |
Why?
|
Mutation, Missense | 1 | 2016 | 2570 | 0.080 |
Why?
|
MicroRNAs | 1 | 2021 | 3587 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2016 | 3425 | 0.070 |
Why?
|
Adult | 7 | 2021 | 211400 | 0.070 |
Why?
|
Young Adult | 3 | 2019 | 56052 | 0.060 |
Why?
|
Female | 8 | 2021 | 375459 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 13603 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5354 | 0.060 |
Why?
|
Kidney | 1 | 2017 | 6744 | 0.060 |
Why?
|
Hematoxylin | 1 | 2020 | 65 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10990 | 0.050 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2021 | 207 | 0.050 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2020 | 75 | 0.050 |
Why?
|
Plasmacytoma | 1 | 2021 | 187 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2019 | 17071 | 0.050 |
Why?
|
Child | 2 | 2019 | 71361 | 0.050 |
Why?
|
Colposcopy | 1 | 2021 | 136 | 0.050 |
Why?
|
Adolescent | 2 | 2019 | 84957 | 0.050 |
Why?
|
Smoking | 1 | 2016 | 9029 | 0.050 |
Why?
|
Chromosome Disorders | 1 | 2021 | 481 | 0.050 |
Why?
|
Skull Base | 1 | 2021 | 256 | 0.040 |
Why?
|
Lung | 1 | 2016 | 9182 | 0.040 |
Why?
|
Plasma Cells | 1 | 2021 | 591 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2020 | 10439 | 0.040 |
Why?
|
Multigene Family | 1 | 2021 | 1200 | 0.040 |
Why?
|
Carboxyhemoglobin | 1 | 2016 | 80 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11115 | 0.040 |
Why?
|
Signal Transduction | 1 | 2021 | 24351 | 0.040 |
Why?
|
Chromosome Deletion | 1 | 2021 | 1385 | 0.040 |
Why?
|
Cotinine | 1 | 2016 | 197 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2018 | 15083 | 0.040 |
Why?
|
Infant | 1 | 2017 | 33918 | 0.040 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2021 | 761 | 0.040 |
Why?
|
Head | 1 | 2021 | 790 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2021 | 60991 | 0.040 |
Why?
|
Cell-Derived Microparticles | 1 | 2016 | 172 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 41159 | 0.030 |
Why?
|
Sputum | 1 | 2016 | 464 | 0.030 |
Why?
|
Thorax | 1 | 2016 | 462 | 0.030 |
Why?
|
Triage | 1 | 2021 | 932 | 0.030 |
Why?
|
HeLa Cells | 1 | 2021 | 3395 | 0.030 |
Why?
|
Pulmonary Alveoli | 1 | 2016 | 669 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 4076 | 0.030 |
Why?
|
Cough | 1 | 2016 | 537 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2016 | 541 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2922 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3789 | 0.030 |
Why?
|
Nicotine | 1 | 2016 | 609 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2017 | 696 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2021 | 4807 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 1739 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2018 | 67320 | 0.030 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2019 | 993 | 0.030 |
Why?
|
Fatigue | 1 | 2017 | 1385 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4415 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2021 | 3296 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 7140 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 10094 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2021 | 3449 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 8182 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 6009 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 15075 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8895 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2016 | 3715 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2021 | 4844 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2017 | 20409 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2021 | 23439 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18495 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 38732 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2016 | 21684 | 0.010 |
Why?
|
Animals | 2 | 2021 | 170849 | 0.010 |
Why?
|
Prospective Studies | 1 | 2021 | 49071 | 0.010 |
Why?
|
Mice | 1 | 2019 | 80803 | 0.010 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_